| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | +6.17% | +1.08% | +5.08% | +8.14% | — |
| 14d | 6 | +66.67% | +3.18% | +3.35% | -0.17% | +4.65% | — |
| 30d | 6 | +50.00% | -1.40% | +5.95% | -6.60% | -3.69% | — |
| 60d | 6 | +33.33% | -17.02% | +1.82% | -28.05% | -30.18% | — |
| 90d | 6(2 pending) | +0.00% | -34.12% | +5.15% | -39.27% | -38.43% | — |
| 180d | 6(4 pending) | +0.00% | -48.65% | +9.15% | -57.80% | -57.80% | — |
| 1y | 6(4 pending) | +0.00% | -78.60% | +20.28% | -98.88% | -98.88% | — |
| 2y | 6(5 pending) | +0.00% | -95.35% | +43.63% | -138.98% | -138.98% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 3,057 | $1.93 | $5.9K | 15,492 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,465 | $2.22 | $5.5K | 12,435 | Jun 15, 2026 | Jun 16, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,129 | $2.57 | $5.5K | 9,970 | May 29, 2026 | Jun 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 1,843 | $2.97 | $5.5K | 7,841 | May 15, 2026 | May 19, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,034 | $2.69 | $5.5K | 6,013 | Apr 30, 2026 | May 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 1,843 | $2.97 | $5.5K | 5,492 | Apr 15, 2026 | Apr 17, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 1,843 | $2.97 | $5.5K | 3,979 | Apr 15, 2026 | Apr 30, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 1,843 | $2.97 | $5.5K | 3,979 | Apr 15, 2026 | May 19, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,136 | $2.54 | $5.4K | 3,649 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,136 | $2.54 | $5.4K | 2,136 | Mar 31, 2026 | Apr 30, 2026 ↗ | View → |
| HURA TUHURA BIOSCIENCES, INC./NV | PURCHASEGRANT Stock grant | 156,240 | — | — | 156,240 | Feb 12, 2026 | Feb 17, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 256,000 | — | — | 256,000 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 768,000 | — | — | 768,000 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,822,471 | — | — | 1,922,471 | Jul 24, 2025 | Jul 28, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 43,600 | — | — | 43,600 | Jan 29, 2025 | Feb 18, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 87,200 | — | — | 87,200 | Jan 29, 2025 | Feb 18, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 87,200 | $0.80 | $69.5K | 87,200 | Jan 27, 2025 | Jan 29, 2025 ↗ | View → |
| HURA TUHURA BIOSCIENCES, INC./NV | PURCHASEGRANT Stock grant | 51,275 | — | — | 51,275 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 10,000 | $2.70 | $27.0K | 20,000 | Jan 30, 2024 | Jan 31, 2024 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,000 | $0.25 | $25.0K | 200,000 | Oct 12, 2023 | Oct 12, 2023 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,000 | $0.25 | $25.0K | 100,000 | Oct 10, 2023 | Oct 10, 2023 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 800,000 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |